Navigation Links
Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine
Date:6/11/2008

ries and received in-country checkups. The study met its primary endpoints, which were designed to evaluate the safety of the vaccine and the incidence of enterotoxigenic E. coli (ETEC) bacteria - the most common cause of travelers' diarrhea. No vaccine-related serious adverse events were reported.

Of the few vaccinated patients who were sickened, the diarrhea lasted only half a day on average, while those in the placebo group endured two days of illness and more than twice as many loose stools. Although not statistically significant, the frequency of new-onset irritable bowel syndrome, a long-term consequence of travelers' diarrhea, was three times greater in placebo than vaccine recipients.

Iomai's vaccine uses an ETEC toxin delivered via a skin patch using the company's novel transcutaneous immunization (TCI) technology. ETEC causes illness through the toxins it produces, including one known as heat-labile toxin or LT. Iomai's unique patch-based vaccine enables the safe administration of this potent immunogen into the skin to stimulate the immune response.

About Travelers' Diarrhea

This year, approximately 55 million international travelers will visit countries where bacteria that cause travelers' diarrhea are endemic, particularly Africa, Asia and Latin America, and about 20 million of those travelers will develop travelers' diarrhea.

A recently completed market study suggested that there is a large market for an effective travelers' diarrhea vaccine, potentially exceeding $750 million annually. If approved, the Iomai vaccine would be the first vaccine for travelers' diarrhea available in the United States.

ETEC's impact goes beyond travelers. The World Health Organization estimates that children in the developing world suffer 210 million episodes of diarrhea caused by ETEC annually, causing 380,000 deaths each year.

About Iomai Cooperation

Iomai Corporation discovers and develops vaccines and immune system
'/>"/>

SOURCE Iomai Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
3. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
4. Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
5. Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
6. Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
7. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2014)... 2014 New ... the Philadelphia Area ... biotechnology company focused on developing pleuromutilins, a new ... caused by resistant gram-positive and gram-negative pathogens, today ... Schmid will remain a member of the ...
(Date:9/3/2014)... ,    ... ~   Kiadis Pharma B.V. ... biopharmaceutical company developing T-cell immunotherapy treatments for blood cancers, ... , MD PhD, as its Chief Medical Officer. ... at Ceronco Biosciences. Prior to that he was VP ...
(Date:9/3/2014)... BUDAPEST, Hungary , Sept. 3, 2014 ... hereinafter: "Palatin") and Gedeon Richter Plc. (hereinafter: "Richter") ... and license agreement to co-develop and commercialize bremelanotide ... European Union, other European countries and additional selected ... with a strong focus in female health and ...
Breaking Medicine Technology:Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer 2Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer 3Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer 4Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 2Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 3Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 4Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 5Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 2Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 3Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 4Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 5
... HORSHAM, Pa. , July 28 Teva Respiratory ... efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol ... all efficacy endpoints, demonstrating a statistically significant benefit as compared to ... similar to placebo. , , ...
... BOCA RATON, Fla. , July 28 ... Pharma, the company will market Methylphenidate Solution, the generic ... an Abbreviated New Drug Application (ANDA).  Under the terms ... Tris Pharma, and marketed and distributed by Breckenridge on ...
Cached Medicine Technology:Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis 2Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis 3Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis 4Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis 5Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis 6Breckenridge Pharmaceutical to Market Methylphenidate Oral Solution Through Agreement With Tris Pharma (Monmouth Junction, NJ) 2
(Date:9/3/2014)... Seattle, Wa (PRWEB) September 03, 2014 ... And Body,” a new report created by Tiffany Chou ... for dealing with skin problems including wrinkles and ... report, people will discover some common causes of wrinkles ... repeated facial expressions ,     Sun exposure: excessive exposure ...
(Date:9/3/2014)... Washington has many auto accidents every ... and have severe consequences as they impact the lives ... discusses how they handle these difficult cases . ... Firm, has worked with trucking accident litigation cases for ... usually backed by multiple lawyers and lots of money, ...
(Date:9/3/2014)... 03, 2014 In light of the ... Flood Law Group , a nationally esteemed personal injury ... the latest information is extremely important. The firm ... spreading awareness by sponsoring a website, designed as a ... their legal right to financial compensation. , Among those ...
(Date:9/3/2014)... AttorneyOne.com, a recognized authority on law, update the ... on Pedigree nutrition for dogs . , Mars ... Pedigree Adult Complete Nutrition dry dog food products are ... material. The reason for the recall is that the product ... packages during the production process. These fragments may present a ...
(Date:9/3/2014)... Columbus, OH (PRWEB) September 03, 2014 ... in quality living options and innovative services for older ... Sarah Moore Health Care Center , (Sarah Moore ... 20 years of experience in the health care industry, ... facilities in Ohio including the MacIntosh Company and HCR ...
Breaking Medicine News(10 mins):Health News:“Home Remedies For Wrinkles And Age Spots On Face And Body,” A New Report On Vkool.com, Reveals Natural And Effective Methods For Dealing With Skin Problems 2Health News:Trucking Litigation Cases are Discussed in Recent Article from The Jones Firm 2Health News:Flood Law Group Spreads Awareness in Wake of Most Recent GM Recall Announcement 2Health News:Pedigree Adult Complete Nutrition for Dogs Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Arnett to Lead Delaware’s Sarah Moore Health Care Center 2
... According to it, the packaging or covering on the ... they claim to be able to cure. ... area of licensed medicines, the National Rules System was ... no scientific proof to confirm their claims will be ...
... study by the UC Davis researchers states that children from ... choosing better after school snacks. // ,The study by ... September issue of the American Journal of Public Health, has ... the vending machines aren't the only places that need to ...
... an increased risk of developing lymphoma and leukemia. The ... pain does have the risk of cancer. //Researchers speculate ... alpha (TNFá) antagonists, a type of biologic DMARD may ... which work by attaching to and impeding chemical messengers ...
... and vegetable juices may have the unique property or reducing the ... examined more than 2,000 people in the study, which appears in ... ,The researchers found that the risk of Alzheimer's was reduced by ... least three times a week as compared to those who drank ...
... past decade saw a decrease in traumatic head injuries ... according to a new report released on Wednesday.// ... hospital admissions for traumatic head injuries from 1994 to ... 35 per cent since 1994, with children and youth ...
... Research Institute are optimistic about a visual device that may ... , ,During a study to gauge the ... was a marked increase in the way the visually impaired ... which comprises of a small camera, pocket-sized computer and see-through ...
Cached Medicine News:Health News:Doctors worried about Homeopathic licensing 2Health News:Kids From Low-Income Groups Could Enhance Their Nutrition By Choosing Better After School Snacks 2Health News:Kids From Low-Income Groups Could Enhance Their Nutrition By Choosing Better After School Snacks 3Health News:RA Drugs Not Implicated In Cancer 2
... synergy T-EP Developed in collaboration with ... and an exceptionally high standard of ... Multimedia technology and design expertise to ... 2, 5 or 10-channel Medelec Synergy ...
Neuropack Sigma MEB-5500 series evoked potential measuring system is a compact, portable, all-in-one unit....
The Nicolet Bravo is a Multi-application system that can configure to meet the needs of neurophysiology deparent....
... of the MYOHANDY family are probably ... MYOQUICK - SystemPLUS line. Based on ... systems of the ISA 100x EP ... ISA 1002 EP) , 4 channels ...
Medicine Products: